enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Why VIVUS Lost in November - AOL

   www.aol.com/news/2012-12-04-why-vivus-lost-in...

   VIVUS' (NAS: VVUS) stock was down 25% for November, though still up 15% for the year. Its drug Qsymia is the first obesity drug to be approved and reach the market in more than a decade, but its ...

3. VVUS: New Ideas for Established Portfolio

   www.aol.com/news/vvus-ideas-established...

   We are initiating coverage of VIVUS, Inc. (VVUS) with a $10.00 price target based on our revenue forecasts for approved products. In addition to a portfolio of weight loss, exocrine pancreatic ...

4. Does The VIVUS, Inc. (NASDAQ:VVUS) Share Price Fall ... - AOL

   www.aol.com/news/does-vivus-inc-nasdaq-vvus...

   For premium support please call: 800-290-4726 more ways to reach us

5. Weight-Loss-Drug Maker Vivus Soars on FDA Panel Review - AOL

   www.aol.com/2010/07/13/vivus-stock-fda-review...

   For premium support please call: 800-290-4726 more ways to reach us

6. Hefty Profits in Store for Obesity-Drug Makers - AOL

   www.aol.com/2012/02/29/hefty-profits-in-store...

   For premium support please call: 800-290-4726 more ways to reach us

7. 3 Reasons to Sell: VIVUS - AOL

   www.aol.com/2012/08/22/3-reasons-to-sell-vivus

   For premium support please call: 800-290-4726 more ways to reach us

8. Areas That VIVUS Investors Must Watch - AOL

   www.aol.com/2012/11/13/areas-vivus-investors...

   For premium support please call: 800-290-4726 more ways to reach us

9. The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

   www.aol.com/news/2013-01-16-the-obesity-drug...

   For premium support please call: 800-290-4726